Cel-Sci
CVM
#10704
Rank
โ‚ฌ19.4 M
Marketcap
1,10ย โ‚ฌ
Share price
-17.69%
Change (1 day)
-79.71%
Change (1 year)

EPS for Cel-Sci (CVM)

EPS in 2026 (TTM): -2,72ย โ‚ฌ

According to Cel-Sci 's latest financial reports the company's current EPS (TTM) is -2,90ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -5,72ย โ‚ฌ an increase over its 2024 EPS that were of -13,96ย โ‚ฌ.

EPS history for Cel-Sci from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,72ย โ‚ฌ-52.35%
2025-5,72ย โ‚ฌ-59.05%
2024-13,96ย โ‚ฌ-30.09%
2023-19,96ย โ‚ฌ-16.09%
2022-23,79ย โ‚ฌ-3.33%
2021-24,61ย โ‚ฌ9.76%
2020-22,43ย โ‚ฌ15.49%
2019-19,42ย โ‚ฌ-62.03%
2018-51,14ย โ‚ฌ2.19%
2017-50,05ย โ‚ฌ-22.78%
2016-64,81ย โ‚ฌ-77.45%
2015-287,43ย โ‚ฌ-13.14%
2014-330,91ย โ‚ฌ61.33%
2013-205,11ย โ‚ฌ-57.14%
2012-478,59ย โ‚ฌ-45.31%
2011-875,14ย โ‚ฌ-420%
2010273,48ย โ‚ฌ-112.9%
2009-2.119ย โ‚ฌ342.86%
2008-478,59ย โ‚ฌ-30%
2007-683,70ย โ‚ฌ-0%
2006-683,70ย โ‚ฌ150%
2005-273,48ย โ‚ฌ-0%
2004-273,48ย โ‚ฌ-75%
2003-1.094ย โ‚ฌ-54.29%
2002-2.393ย โ‚ฌ-31.37%
2001-3.487ย โ‚ฌ15.91%
2000-3.008ย โ‚ฌ-8.47%
1999-3.287ย โ‚ฌ-29.73%
1998-4.677ย โ‚ฌ-26%
1997-6.320ย โ‚ฌ-13.79%
1996-7.331ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,09ย โ‚ฌ-310.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
15,84ย โ‚ฌ-646.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-1,43ย โ‚ฌ-50.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-12,96ย โ‚ฌ 347.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
0,41ย โ‚ฌ-114.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
-1,23ย โ‚ฌ-57.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-4,59ย โ‚ฌ 58.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-26,70ย โ‚ฌ 821.07%๐Ÿ‡บ๐Ÿ‡ธ USA